Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Ketogenic Diet and Ketamine for Anorexia Nervosa
NCT04714541Phase 1Completed
- Sponsor
- Homeostasis Therapeutics
- Start
- Apr 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ketamine in anorexia nervosa (AN), sponsored by Homeostasis Therapeutics. Primary endpoints: Eating Disorder Examination Questionnaire at 12 months, Eating Disorder Recovery Endorsement Questionnaire at 12 months and 2 more. Started Apr 2021; status: completed.
02
Drugs
ketamine
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT04714541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04714541.